Integra Lifesciences Holdings Corp’s recently made public that its Exec. Chairman of the Board ESSIG STUART acquired Company’s shares for reported $1.5 million on May 23 ’24. In the deal valued at $28.49 per share,52,641 shares were bought. As a result of this transaction, ESSIG STUART now holds 487,922 shares worth roughly $14.27 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, HILL BARBARA B bought 36,350 shares, generating $995,816 in total proceeds. Upon buying the shares at $27.40, the Director now owns 36,350 shares.
Before that, DAVIS ROBERT T. JR. sold 8,348 shares. Integra Lifesciences Holdings Corp shares valued at $305,492 were divested by the EVP & President, TT at a price of $36.59 per share. As a result of the transaction, DAVIS ROBERT T. JR. now holds 49,893 shares, worth roughly $1.46 million.
Wells Fargo downgraded its Integra Lifesciences Holdings Corp [IART] rating to an Equal weight from a an Overweight in a research note published on May 07, 2024; the price target was decreased to $25 from $45. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who decreased its forecast for the stock in early May from “an Outperform” to “a Perform”. Citigroup also remained covering IART and has increased its forecast on April 03, 2024 with a “Neutral” recommendation from previously “Sell” rating. Wells Fargo revised its rating on December 05, 2023. It rated IART as “an Overweight” which previously was an “an Equal weight”.
Price Performance Review of IART
On Friday, Integra Lifesciences Holdings Corp [NASDAQ:IART] saw its stock jump 1.39% to $29.25. Over the last five days, the stock has lost -5.03%. Integra Lifesciences Holdings Corp shares have fallen nearly -32.84% since the year began. Nevertheless, the stocks have fallen -28.15% over the past one year. While a 52-week high of $46.75 was reached on 02/20/24, a 52-week low of $22.36 was recorded on 05/06/24. SMA at 50 days reached $29.42, while 200 days put it at $36.99. A total of 1.28 million shares were traded, compared to the trading of 0.96 million shares in the previous session.
Levels Of Support And Resistance For IART Stock
The 24-hour chart illustrates a support level at 28.80, which if violated will result in even more drops to 28.35. On the upside, there is a resistance level at 29.56. A further resistance level may holdings at 29.86. The Relative Strength Index (RSI) on the 14-day chart is 47.94, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.24, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 78.50%. Stochastics %K at 23.22% indicates the stock is a holding.
The most recent change occurred on November 14, 2023 when CL King began covering the stock and recommended ‘”a Buy”‘ rating along with a $50 price target.
